James Samuel Shannon Xilio Therapeutics, Inc. (XLO) insider trading activity
James Samuel Shannon is of Xilio Therapeutics, Inc.. Currently has a direct ownership of 70,000 shares of XLO, which is worth approximately $47,600. The most recent transaction as insider was on Jun 17, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $17,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
70K
n/a
3M change
n/a
12M change
Total Value Held
$47,600
James Samuel Shannon Transaction History
Also insider at
JSS
James Samuel Shannon
Dublin, L2